Size | Price | Stock | Qty |
---|---|---|---|
1mg |
|
||
5mg |
|
||
10mg |
|
||
Other Sizes |
|
Targets |
SOS1[1].
|
---|---|
ln Vitro |
The average OD value in the control group minus the average OD value in the treatment group divided by the average OD value in the control group×100% yields the growth inhibitory rate (IR), which is compared. The growth inhibitory rate of NSC-70220 at 40 μM and NSC-658497 at 30 μM treatments is 29% and 8%, respectively. The growth inhibitory rate of 54% obtained from the combination treatment demonstrates the synergistic effect of NSC-658497 and NSC-70220 on the suppression of cell growth. It was demonstrated that P-AKT and P-ERK expression levels were decreased following treatment with NSC-658497 at 40 μM for two hours either alone or in combination with treatment with 40 μM of NSC-70220 overnight. P-ERK expression levels decreased over night after treatment with 40 μM of NSC-70220[1].
|
References |
[1]. ARYL SULFONOHYDRAZIDES. WO 2016077793A1
|
Molecular Formula |
C22H15NO2
|
---|---|
Molecular Weight |
325.36
|
Exact Mass |
325.11
|
CAS # |
4551-00-2
|
PubChem CID |
6184791
|
Appearance |
Typically exists as solid at room temperature
|
Density |
1.321g/cm3
|
Boiling Point |
569.6ºC at 760 mmHg
|
Flash Point |
274.9ºC
|
Index of Refraction |
1.767
|
LogP |
6.243
|
Hydrogen Bond Donor Count |
0
|
Hydrogen Bond Acceptor Count |
2
|
Rotatable Bond Count |
2
|
Heavy Atom Count |
25
|
Complexity |
523
|
Defined Atom Stereocenter Count |
0
|
SMILES |
O=[N+]([O-])C1=CC=CC=C1/C=C/C=C2C3=CC=CC=C3C4=CC=CC=C\24
|
InChi Key |
DAVRONXTELQQCO-VQHVLOKHSA-N
|
InChi Code |
InChI=1S/C22H15NO2/c24-23(25)22-15-6-1-8-16(22)9-7-14-21-19-12-4-2-10-17(19)18-11-3-5-13-20(18)21/h1-15H/b9-7+
|
Chemical Name |
9-[(E)-3-(2-nitrophenyl)prop-2-enylidene]fluorene
|
HS Tariff Code |
2934.99.9001
|
Storage |
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month Note: This product is not stable in solution, please use freshly prepared working solution for optimal results. |
Shipping Condition |
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|
Solubility (In Vitro) |
DMSO: 12.5 mg/mL (38.42 mM)
|
---|---|
Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 1.25 mg/mL (3.84 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 12.5 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL. Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution. Solubility in Formulation 2: ≥ 1.25 mg/mL (3.84 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 12.5 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.  (Please use freshly prepared in vivo formulations for optimal results.) |
Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
1 mM | 3.0735 mL | 15.3676 mL | 30.7352 mL | |
5 mM | 0.6147 mL | 3.0735 mL | 6.1470 mL | |
10 mM | 0.3074 mL | 1.5368 mL | 3.0735 mL |
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.
Calculation results
Working concentration: mg/mL;
Method for preparing DMSO stock solution: mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation::Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O,mix and clarify.
(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
(2) Be sure to add the solvent(s) in order.